BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

930 related articles for article (PubMed ID: 30415233)

  • 21. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival.
    Rudler M; Cluzel P; Corvec TL; Benosman H; Rousseau G; Poynard T; Thabut D
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1074-80. PubMed ID: 25230051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
    Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
    J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population.
    Rosenqvist K; Sheikhi R; Nyman R; Rorsman F; Sangfelt P; Ebeling Barbier C
    Scand J Gastroenterol; 2018 Jan; 53(1):70-75. PubMed ID: 28990812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
    Holster IL; Tjwa ET; Moelker A; Wils A; Hansen BE; Vermeijden JR; Scholten P; van Hoek B; Nicolai JJ; Kuipers EJ; Pattynama PM; van Buuren HR
    Hepatology; 2016 Feb; 63(2):581-9. PubMed ID: 26517576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
    Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
    Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
    Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
    [No Abstract]   [Full Text] [Related]  

  • 28. Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials.
    Halabi SA; Sawas T; Sadat B; Jandali A; Halabi HA; Halabi FA; Kapoor B; Carey WD
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1519-26. PubMed ID: 26858143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding.
    Benedeto-Stojanov D; Nagorni A; Bjelaković G; Stojanov D; Mladenović B; Djenić N
    Vojnosanit Pregl; 2009 Sep; 66(9):724-8. PubMed ID: 19877551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding.
    Rout G; Sharma S; Gunjan D; Kedia S; Saraya A; Nayak B; Singh V; Kumar R; Shalimar
    Dig Dis Sci; 2019 Aug; 64(8):2327-2337. PubMed ID: 30830520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS.
    Xia Y; Tie J; Wang G; Zhuge Y; Wu H; Xue H; Xu J; Zhang F; Zhao L; Huang G; Zhang M; Wei B; Li P; Wu W; Chen C; Tang C; Zhang C
    Hepatol Int; 2023 Aug; 17(4):967-978. PubMed ID: 36807252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing in-hospital mortality for salvage percutaneous transjugular intrahepatic portosystemic shunting in cirrhotic patients with recalcitrant variceal bleeding after failed endoscopic intervention.
    Krige JEJ; Jonas EG; Setshedi M; Beningfield SJ; Lotze UK; Bernon MM; Burmeister S; Kloppers JC
    S Afr Med J; 2023 Dec; 114(1):39-43. PubMed ID: 38525611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial).
    Tripathi D; Patch D; Mehrzad H; Yu D; Aspinall RJ; Armstrong MJ; Stanley A; Ireland H; Travis S; Hayes P; Lomax M; Roslund N; Lam E; Slinn G; Jowett S; Moakes C; Maher A; Brettell E; Sehmi S;
    BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38519049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H; Marinova M
    Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.
    Tzeng WS; Wu RH; Lin CY; Chen JJ; Sheu MJ; Koay LB; Lee C
    Korean J Radiol; 2009; 10(5):481-9. PubMed ID: 19721833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation.
    Ardevol A; Alvarado-Tapias E; Garcia-Guix M; Brujats A; Gonzalez L; Hernández-Gea V; Aracil C; Pavel O; Cuyas B; Graupera I; Colomo A; Poca M; Torras X; Concepción M; Villanueva C
    Dig Liver Dis; 2020 Sep; 52(9):1017-1025. PubMed ID: 32653417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis.
    Orloff MJ; Hye RJ; Wheeler HO; Isenberg JI; Haynes KS; Vaida F; Girard B; Orloff KJ
    Surgery; 2015 Jun; 157(6):1028-45. PubMed ID: 25957003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic efficacy of transjugular intrahepatic portosystemic shunt on bleeding gastric varices].
    Song HG; Lee HC; Park YH; Jung S; Chung YH; Lee YS; Yoon HK; Sung KB; Suh DJ
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):448-57. PubMed ID: 12506249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.